Converting Enzyme Inhibitor or AT1-Receptor Blocker for Decreasing Long-Term Mortality in Patients With Stroke History and Renal Dysfunction?

Stroke - United States
doi 10.1161/01.str.0000044950.15362.a4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic

Archives of Internal Medicine
2005English

The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death

International Journal of Clinical Medicine
2017English

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Anticipated Combination of Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor: New Opportunities for Optimizing Treatment of Cardiovascular Patients

HYPERTENSION
2017English

Author Correction: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Monotherapy Retard Deterioration of Renal Function in Taiwanese Chronic Kidney Disease Population

Scientific Reports
Multidisciplinary
2020English

Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

?Escape? Of Aldosterone Production in Patients With Left Ventricular Dysfunction Treated With an Angiotensin Converting Enzyme Inhibitor: Implications for Therapy

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
1995English

Transition From Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Ii-Receptor-Blocker to Sacubitril/Valsartan in Chronic Heart Failure Patients: Initial Experiences in Clinical Practice

Cor et Vasa
Cardiovascular MedicineCardiology
2018English

Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure

Journal of Cardiovascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy